BNGO
Price
$1.11
Change
+$0.02 (+1.83%)
Updated
Mar 28, 6:59 PM EST
PACB
Price
$3.79
Change
+$0.07 (+1.88%)
Updated
Mar 28, 2:20 PM EST
35 days until earnings call
Ad is loading...

Compare trend and price BNGO vs PACB

Header iconBNGO vs PACB Comparison
Open Charts BNGO vs PACBBanner chart's image
Bionano Genomics
Price$1.11
Change+$0.02 (+1.83%)
Volume$944.36K
CapitalizationN/A
Pacific Biosciences of California
Price$3.79
Change+$0.07 (+1.88%)
Volume$4.69K
CapitalizationN/A
View a ticker or compare two or three
BNGO vs PACB Comparison Chart

Loading...

BNGODaily Signal changed days agoGain/Loss if shorted
 
Show more...
PACBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BNGO vs. PACB commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a StrongBuy and PACB is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BNGO: $1.11 vs. PACB: $3.72)
Brand notoriety: BNGO and PACB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 66% vs. PACB: 84%
Market capitalization -- BNGO: $59.07M vs. PACB: $996.78M
BNGO [@Medical Specialties] is valued at $59.07M. PACB’s [@Medical Specialties] market capitalization is $996.78M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whilePACB’s FA Score has 0 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • PACB’s FA Score: 0 green, 5 red.
According to our system of comparison, BNGO is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 5 TA indicator(s) are bullish while PACB’s TA Score has 4 bullish TA indicator(s).

  • BNGO’s TA Score: 5 bullish, 2 bearish.
  • PACB’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than PACB.

Price Growth

BNGO (@Medical Specialties) experienced а +4.72% price change this week, while PACB (@Medical Specialties) price change was -2.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.98%. For the same industry, the average monthly price growth was -0.07%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

BNGO is expected to report earnings on Nov 09, 2023.

PACB is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Medical Specialties (+0.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BNGO with price predictions.
OPEN
A.I.dvisor published
a Summary for PACB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PACB($997M) has a higher market cap than BNGO($59.1M). BNGO YTD gains are higher at: -41.270 vs. PACB (-62.080). BNGO has higher annual earnings (EBITDA): -213.4M vs. PACB (-277.28M). PACB has more cash in the bank: 631M vs. BNGO (102M). BNGO has less debt than PACB: BNGO (79.4M) vs PACB (934M). PACB has higher revenues than BNGO: PACB (201M) vs BNGO (36.1M).
BNGOPACBBNGO / PACB
Capitalization59.1M997M6%
EBITDA-213.4M-277.28M77%
Gain YTD-41.270-62.08066%
P/E RatioN/AN/A-
Revenue36.1M201M18%
Total Cash102M631M16%
Total Debt79.4M934M9%
FUNDAMENTALS RATINGS
PACB: Fundamental Ratings
PACB
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNGOPACB
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BNGODaily Signal changed days agoGain/Loss if shorted
 
Show more...
PACBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWADX8.230.14
+1.73%
American Century Value A
FCLKX14.300.14
+0.99%
Fidelity Large Cap Stock K6
JVLIX24.670.23
+0.94%
JHancock Disciplined Value I
SFECX10.840.10
+0.93%
Guggenheim StylePlus - Large Core C
IVFAX3.660.02
+0.61%
Federated Hermes Intl Strat Val Div A

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with MASI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
+5.68%
MASI - PACB
58%
Loosely correlated
+2.72%
TWST - PACB
56%
Loosely correlated
+2.13%
IQV - PACB
46%
Loosely correlated
+1.95%
EXAS - PACB
46%
Loosely correlated
+2.54%
ILMN - PACB
45%
Loosely correlated
+3.65%
More